ReviewCancers2023

Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy.

Vatsala Katiyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.